期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

二甲双胍对2型糖尿病患者甲状腺功能的影响

下载PDF
导出
摘要 二甲双胍是临床上治疗2型糖尿病的常用药物，被普遍认为是一种较为安全、有效的药物。近年来有多项研究报道，二甲双胍对2型糖尿病患者甲状腺功能有一定的影响，现笔者将相关的研究进展作一综述。
作者 费扬 李红
机构地区 浙江大学医学院附属邵逸夫医院内分泌科 富阳市人民医院内分泌科工作
出处 《浙江医学》 CAS 2010年第7期1116-1118,共3页 Zhejiang Medical Journal
关键词 2型糖尿病 甲状腺功能 二甲双胍 患者 常用药物
分类号 R587.1 [医药卫生—内分泌]
  • 相关文献

参考文献17

  • 1Kurukulasuriya R,Banerji M A,Chaiden R,et al.Selective decrease in visceral fat is associated with weight loss during metformin treatment in african americans with type 2 diabetes[J].Diabetes,1999,489:A315.
  • 2Roden M.Petersen K F,Shulman G I.Nuclear magnetic resonance studies of hepatic glucose metabolism in humans[J].Recent Prog Horm Res,2001,56:219-237.
  • 3Stumvoll M,Nurjhan N,Perriello G,et al.Metabolic effects of metformin in non-insulin-dependent diabetes mellitus[J].N Engl J Med,1995,333:550-554.
  • 4Hundal R S,Krssak M,Dufour S.et al.Mechanism by which metformin reduces glucose production in type 2 diabetes[J].Diabetes,2000,49:2063-2069.
  • 5Chu N V,Kong A P S,Kim D D,et al.Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes[J].Diabetes Care,2002,25.542-549.
  • 6Edgerton D S,Johnson K M,Cherrington A D.Current strategies for the inhibition of hepatic glucose production in type 2 diabetes[J].Front Biosci,2009,14:1169-1181.
  • 7Misra P,Chakrabarti R.The role of AMP kinase in diabetes[J].Indian J Med Res,2007,125:389-398.
  • 8Kim Y D,Park K G,Lee Y S,et al.Metformin inhibits hepatic gluconeogenesis through AMP-activated protein kinase-dependent regulation of the orphan nuclear receptor SHP[J].Diabetes,2008,57:306-314.
  • 9Vondra K,Vrbikova J.Drorakova K.Thyroid gland disease in adult patients with diabetes mellitus[J].Minerva Endocrinol,2005,30:217-236.
  • 10Radaideh A R,Nusier M K,Amari F L,et al.Thyriod dysfunction in patients with type 2 diabetes mellitus in Jordan[J].Sandi Med J.2004,23:1046-1050.

二级参考文献15

  • 1张宏,卢军,赵伟,郑凝,谢云,张秋梅,董如娇,方佩华.T2DM合并甲状腺肿患者心血管疾病患病情况的初步探讨[J].天津医科大学学报,2005,11(3):423-425. 被引量：11
  • 2张宏,白景文,赵伟,郑凝,董如娇,卫丽君,方佩华.糖尿病大鼠甲状腺组织的超微病理改变[J].天津医药,2006,34(2):108-110. 被引量：39
  • 3Vondra K, Vrbikova J, Dvorakova K. Thyroid gland diseases in adult patients with diabetes mellitus. Minerva Endocrinol,2005,30:217-236.
  • 4Pimenta WP, Mazeto GM, Callegaro CF, et al. Thyriod disorders in diabetic patients. Arq Bras Endocrinol Metabol,2005,49:234-240.
  • 5Radaideh APt, Nusier MK, Amari FL, et al. Thyriod dysfunction in patients with type 2 diabetes mellitus in Jordan. Saudi Med J, 2004, 25:1046-1050.
  • 6Michael W,Tunbridge C, Vanderpump MP. Population screen for autoimmue thyroid disease. Endocrinol Metab North Am,2000,29:239-2.54.
  • 7Chubb SA, Davis WA, Inman Z, et al. Prevalence and progression of subclinical hypothyroidism in women with type 2 diabetes:the Fremantle Diabetes Study. Clin Endocrinol (Oxf) ,2005,62:480-486.
  • 8Vigersky RA, Filmore-Nassar A, Glass AR. Thyrotropin suppression by metformin. J Clin Endocrinol Metab, 2006, 91:225-227.
  • 9Isidro ML, Penin MA, Nemifia R,et al. Metformin reduces thyrotropin levels in obese, diabetic women with primary hypothyroidism on thyroxine replacement therapy. Endocrine, 2007,32:79-82.
  • 10Scheen AJ. Clinical pharmacokinetics of metformin. Clin Pharma cokinet, 1996,30 : 359-371.

共引文献87

浙江医学
2010年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部